Based on previous studies,3, 4, 5, 6, 7 cancer cell‐based models that stably express the survivin promoter‐luciferase reporter as a biomarker were created8 and used in high‐throughput screening campaigns against various compound libraries, followed by in vitro and in vivo hit‐to‐lead analyses.9 This evidence concerns the gene BIRC5 and cancer.